BioCentury
ARTICLE | Clinical News

Detrol LA tolterodine ER: Phase IV discontinued

July 16, 2012 7:00 AM UTC

Pfizer said it discontinued enrollment in the double-blind, placebo-controlled, U.S. Phase IV REMOTE trial evaluating daily 4 mg Detrol LA after the enrollment rate did not meet its expectations. The ...